Viemed Healthcare (VMD) Insider Smokoff Sells $230K of Stock

Insider Buying and Selling at Viemed Healthcare, Inc.

Insider Timothy Smokoff executed a sale of 20,000 shares of Viemed Healthcare, Inc. (NasdaqCM: VMD) on June 24, 2026. The transaction took place at an average price of $11.50 per share, resulting in a total value of $229,968. Such filings offer a window into how executives manage their personal holdings, though routine sales do not inherently signal a directional outlook for the business.

Recent Insider Transactions at Viemed

This summer has brought a flurry of executive transactions across the firm. Chief Medical Officer William Frazier also made headlines with multiple trades on June 25, 2026. Frazier picked up 10,000 shares at a price of $1.81 for a total value of $18,100, while also unloading 10,000 shares at a price of $11.72 for a total value of $117,200. These moves follow earlier executive sales in June, keeping market watchers busy tracking leadership adjustments.

Stock Valuation and Price Performance

Viemed shares change hands close to the upper bound of their yearly price band. The stock has moved between a low of $6.05 and a high of $12.61 over the past year. With a price-to-earnings ratio of 24.58 and a forward P/E ratio of 22.13, the medical equipment supplier trades well above its 50-day moving average of $9.97 and its 200-day moving average of $9.25.

Wall Street Analyst Views

Analyst opinion on Viemed varies as new research notes arrive from major firms. On August 24, 2026, Barrington Research initiated coverage on the company with an Outperform rating and a $14.00 price target. Earlier in the month on August 6, 2026, Freedom Broker adjusted its stance by issuing a Hold rating alongside an $11.00 price target. Overall consensus points to a mean price target of $12.50 across available opinions.

Home Medical Equipment and Respiratory Care

Viemed Healthcare operates out of Lafayette, Louisiana, providing home medical equipment and specialized respiratory therapy solutions across the United States. The company focuses on chronic obstructive pulmonary disease management, ventilators, sleep apnea devices, and oxygen therapy services to support patients in post-acute care settings. Executive and insider transactions often accompany periods of operational growth as the enterprise expands its medical device footprint.

What to Watch at Viemed Healthcare, Inc.

Investors tracking Viemed Healthcare can look forward to the next earnings report scheduled for November 4, 2026, for further financial updates. Future regulatory filings will also show whether executives continue adjusting their personal share counts as the business approaches its next round of results.